NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells

Molecular and Cellular Biochemistry

Volumn 393, Issue 1-2, 2014, Pages 265-270

  Liu, Cheng ^a   Li, Zhuohang ^a   Bi, Liangkuan ^a   Li, Kuiqing ^a   Zhou, Bangfen ^a   Xu, Chen ^a   Huang, Jian ^a   Xu, Kewei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

ABCC1; Chemoresistance; NOTCH1; Prostate cancer stem cells

Indexed keywords

MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; NOTCH1 RECEPTOR; SHORT HAIRPIN RNA; DOCETAXEL; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; NOTCH1 PROTEIN, HUMAN; TAXOID;

ARTICLE; CANCER CHEMOTHERAPY; CANCER STEM CELL; CELL ISOLATION; CELL VIABILITY; CHEMOREACTIVITY; CHEMORESISTANCE; CHEMOSENSITIVITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; PROMOTER REGION; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROSTATE CANCER STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BIOSYNTHESIS; CELL PROLIFERATION; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PROSTATIC NEOPLASMS;

CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASTIC STEM CELLS; PROSTATIC NEOPLASMS; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; TAXOIDS;

EID: 84903446187     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2069-4     Document Type: Article

References (29)

1. Al-Hajj M (2007) Cancer stem cells and oncology therapeutics. Curr Opin Oncol 19:61-64
2. Polyak K, Hahn WC (2006) Roots and stems: stem cells in cancer. Nat Med 12:296-300 (Pubitemid 43355075)
3. Jordan CT, Guzman ML, Noble M (2006) Cancer stem cells. N Engl J Med 355:1253-1261 (Pubitemid 44427449)
4. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65:10946-10951 (Pubitemid 41713363)
5. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-115 (Pubitemid 46067311)
6. Marian CO, Shay JW (2009) Prostate tumor-initiating cells: a new target for telomerase inhibition therapy? Biochim Biophys Acta 1792:289-296
7. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT (2004) CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117:3539-3545 (Pubitemid 39206394)
8. Hu Y, Fu L (2012) Targeting cancer stem cells: a new therapy to cure cancer patients. Am J Cancer Res 2(3):340-356
9. Radtke F, Raj K (2003) The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 3(10):756-767 (Pubitemid 37328814)
10. Li Y, Hibbs MA, Gard AL, Shylo NA, Yun K (2012) Genomewide analysis of N1ICD/RBPJ targets in vivo reveals direct transcriptional regulation of Wnt, SHH, and hippo pathway effectors by Notch1. Stem Cells 30(4):741-752
11. Espinosa L, Cathelin S, D'Altri T et al (2010) The Notch/Hes1 pathway sustains NF-kappaB activation through CYLD repression in T cell leukemia. Cancer Cell 18(3):268-281
12. McAuliffe SM, Morgan SL, Wyant GA et al (2012) Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. Proc Natl Acad Sci USA 109(43):E2939-E2948
13. Cho S, Lu M, He X et al (2011) Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells. Proc Natl Acad Sci USA 108(51):20778-20783
14. Li K, Liu C, Zhou B et al (2013) Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells. Int J Mol Sci 14(6):11981-11993
15. Ling H, Jolicoeur P (2013) Notch-1 signaling promotes the cyclinD1-dependent generation of mammary tumor-initiating cells that can revert to bi-potential progenitors from which they arise. Oncogene 32(29):3410-3419
16. Neradugomma NK, Subramaniam D, Tawfik O et al (2014) Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner. Carcinogenesis 35(4):795-806
17. Licciulli S, Avila JL, Hanlon L et al (2013) Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53. Cancer Res 73(19):5974-5984
18. Nooter K, Westerman AM, Flens MJ et al (1995) Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin Cancer Res 1(11):1301-1310
19. Norris MD, Bordow SB, Marshall GM, Haber PS, Cohn SL, Haber M (1996) Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med 334(4):231-238 (Pubitemid 26032215)
20. Fan X, Liu S, Su F, Pan Q, Lin T (2012) Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system. Urol Oncol 30(3):314-318
21. + stem/progenitor cells to battle prostate cancer. J Biol Chem 288(23):16476-16483
22. Prasetyanti PR, Zimberlin CD, Bots M, Vermeulen L, De Sousa EMF, Medema JP (2013) Regulation of stem cell self-renewal and differentiation by Wnt and Notch are conserved throughout the adenoma-carcinoma sequence in the colon. Mol Cancer 12(1):126
23. Suman S, Das TP, Damodaran C (2013) Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells. Br J Cancer 109(10):2587-2596
24. Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V et al (2012) Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells. Cancer Cell 22(3):373-388
25. Qiu M, Peng Q, Jiang I et al (2013) Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells. Cancer Lett 328(2):261-270
26. Jin F, Zhao L, Guo YJ et al (2010) Influence of Etoposide on antiapoptotic and multidrug resistance-associated protein genes in CD133 positive U251 glioblastoma stem-like cells. Brain Res 1336:103-111
27. Vesuna F, Lisok A, Kimble B, Raman V (2009) Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia 11:1318-1328
28. + population in hepatocellular carcinoma. Int J Cancer 126:2067-2078
29. Tokar EJ, Qu W, Liu J et al (2010) Arsenic-specific stem cell selection during malignant transformation. J Natl Cancer Inst 102:638-649